J West Afr Coll Surg. 2016 Jan-Mar;6(1):47-69.
EFFICACY OF INTRAVENOUS ESMOLOL VERSUS LIDOCAINE FOR ATTENUATION OF THE PRESSOR RESPONSE IN NIGERIANS.
Journal of the West African College of Surgeons
J O Olatosi, A Ehiozie-Osifo
Affiliations
Affiliations
- Department of Anaesthesia, Lagos University Teaching Hospital, Lagos, Nigeria.
PMID: 28344937
PMCID: PMC5342620
Abstract
BACKGROUND: Laryngoscopy and tracheal intubation are an integral component of airway management and general anaesthesia. Direct stimulation of the pharynx and larynx by the laryngoscope blade and the insertion of an endotracheal tube elicit a sympathetic nervous system response with a reflex consisting of a transient increase in blood pressure, heart rate, and the occurrence of cardiac dysrhythmias referred to as the 'pressor' response. This may be of major clinical significance in patients with pre-existing systemic hypertension, hypertensive heart disease, coronary artery disease, eclampsia, aneurysmal vascular disease and head injury in whom such a change may culminate in perioperative myocardial ischaemia or infarction, cardiac failure, dysrhythmias, cerebrovascular accidents or secondary brain injury.
AIM: To evaluate and compare the effects of intravenous lidocaine and esmolol on the pressor response as well as determine the occurrence of complications with the use of either agent in a Nigerian population.
METHODOLOGY: Ninety adult ASA I and II patients undergoing elective non-cardiac surgery under general anaesthesia were randomly allocated to one of 3 groups; group E: 2mg.kg
RESULTS: Mean heart rate increased by 19.1%, 25.7%, and 41.4%, SBP increased 13.3%, 21.6% and 26.9%, MAP by 12.2%, 19.1% and 30.2%, RPP by 28.1%, 45.8% and 78.7% in groups E, L and C respectively post intubation. There were no complications attributable to the use of either agent.
CONCLUSION: Intravenous esmolol 2mg.kg
Keywords: Blood pressure; Esmolol; Heart rate; Intubation; Laryngoscopy; Lidocaine
Conflict of interest statement
Competing Interests: The authors have declared that no competing interests exist.
References
- Br J Anaesth. 1983 Sep;55(9):855-60 - PubMed
- Can J Anaesth. 1991 Oct;38(7):849-58 - PubMed
- Anesthesiology. 1977 Dec;47(6):524-5 - PubMed
- Br J Anaesth. 2006 Jun;96(6):769-73 - PubMed
- Anesth Analg. 1991 Apr;72(4):482-6 - PubMed
- Eur J Anaesthesiol. 2008 Jun;25(6):517-9 - PubMed
- J Clin Anesth. 1992 Sep-Oct;4(5):367-71 - PubMed
- Clin Pharmacol Ther. 1987 Jan;41(1):112-7 - PubMed
- Can Anaesth Soc J. 1977 Jan;24(1):12-9 - PubMed
- Anesthesiology. 1983 Dec;59(6):499-505 - PubMed
- Anesthesiology. 1951 Sep;12(5):556-66 - PubMed
- Lancet Glob Health. 2015 Sep;3(9):e514-5 - PubMed
- Anesth Analg. 1989 Jun;68(6):772-6 - PubMed
- Anesthesiology. 1981 Nov;55(5):578-81 - PubMed
- J Emerg Med. 1994 Jul-Aug;12(4):499-506 - PubMed
- Br J Anaesth. 1971 Jun;43(6):531-47 - PubMed
- Acta Anaesthesiol Sin. 1996 Jun;34(2):61-7 - PubMed
- Can J Anaesth. 2001 Sep;48(8):732-6 - PubMed
Publication Types